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Abstract
Objective To evaluate the ability of international point of care information
summaries to update evidence relevant to medical practice.
Design Prospective cohort bibliometric analysis.
Setting Top five point of care information summaries (Clinical Evidence,
EBMGuidelines, eMedicine, Dynamed, UpToDate) ranked for coverage
of medical conditions, editorial quality, and evidence based methodology.
Main outcome measures From June 2009 to May 2010 we measured
the incidence of research findings relating to potentially eligible
newsworthy evidence. As samples, we chose systematic reviews rated
as relevant by international research networks (such as, Evidence-Based
Medicine, ACP Journal Club, and the Cochrane Collaboration). Every
month we assessed whether each sampled review was cited in at least
one chapter of the five summaries. The cumulative updating rate was
analysed with Kaplan-Meier curves.
Results From April to December 2009, 128 reviews were retrieved; 53%
(68) from the literature surveillance journals and 47% (60) from the
Cochrane Library. At nine months, Dynamed had cited 87% of the
sampled reviews, while the other summaries had cited less than 50%.
The updating speed of Dynamed clearly led the others. For instance,
the hazard ratios for citations in EBM Guidelines and Clinical Evidence
versus the top performer were 0.22 (95% confidence interval 0.17 to
0.29) and 0.03 (0.01 to 0.05).
Conclusions Point of care information summaries include evidence
relevant to practice at different speeds. A qualitative analysis of updating
mechanisms is needed to determine whether greater speed corresponds
to more appropriate incorporation of new information.
Introduction
As biomedicine evolves with the accumulation of new research
andpublications,promisinghealthcareinterventionscanemerge
while others become out of date or suboptimal.
1 2 Sound
evidence—together with contextual factors, values, resources,
etc—forms the basic framework on which healthcare decisions
should rest. Failure to incorporate results of new research into
practice can affect individual and population outcomes. This is
the main reason for updating any medical information sources
suchassystematicreviews,guidelines,andclinicalsummaries.
Comprehensive presentation of new findings from research
against the background of what is already available is essential
tomeetdoctors’needsforevidenceduringclinicalconsultations:
which interventions work, which don’t work, which are
additional or alternative, which need more investigation, and
which might be harmful. For internet based information in
particular, doctors and health professionals expect to rapidly
find the latest knowledge to answer their information needs.
Point of care information summaries are web based
compendiums designed to provide health professionals with
comprehensive evidence condensed into easily digestible
formats. The innovative aspect of these tools relies on how the
information is engineered to be used at the point of care, when
patientandpractitionerinteract.Pointofcarecontentislogically
grouped around common medical scenarios and translated into
alternative options related to diagnosis, treatment, and
management.
3 Publishers encourage physicians to use them
during consultations or as a second opinion in their clinical
decision making.
Tomakethemattractivetofinalusers,allpublishersclaimthese
productsareregularlyupdated.Someevenmakedirectreference
to the dynamic incorporation of the latest evidence in their
commercialnames.Todeterminehowlongittakesforthelatest
researchfindingstomaketheirwayintoapointofcaresummary
we conducted a bibliometric analysis to examine the speed of
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Research
RESEARCHupdating—that is, the time between a paper’s publication and
its citation in a point of care summary. For this analysis, we
considered only papers with implications relevant to practice.
Methods
Out of 18 point of care information services available in 2008,
we selected Clinical Evidence, Dynamed, EBM Guidelines,
eMedicine,andUpToDate.Thesewererankedinthetopquarter
for at least two desirable dimensions: coverage of medical
conditions (volume) and editorial quality and evidence based
methodology.
3 Our reasoning was that updating is a further
desirabledimensionofpointofcaresummariesontopofothers,
and it would have been useless to look at the updating speed of
products that were suboptimal in other dimensions on the basis
of our evaluation. The decision to limit our analysis to the top
rankingsummariesreflectedtheaimofourresearch,whichwas
to help users select one product over others.
For each of the five point of care information summaries we
collected data on the updating mechanism by examining the
free access web pages and sending emails to the information
request service and editorial teams, as needed. This cross
sectional qualitative analysis was done only once, in December
2009.
To evaluate updating speed we measured the incidence of
research findings cited in point of care information summaries
on potentially eligible newsworthy pieces of information. As
samplesofinformationrelevanttopracticewechosesystematic
reviews, which aim to provide a comprehensive appraisal of
evidence. Findings from a single clinical trial are often rapidly
contradicted by subsequent studies and low bias systematic
reviews could help to get closer to the unknown “true
evidence.”
4-6 Systematic reviews have also gained acceptance
asastartingpointinthedevelopmentofevidencebasedclinical
practice guidelines.
7 High quality systematic reviews are used
more and are rated more highly by physicians in terms of
relevancetoclinicalpracticethanotherdesignsofarticles.
8Four
of the five point of care summaries we included clearly give
priority to systematic reviews (and in general a cumulative
approach to evidence) than other types of publications.
3 We
were not able to retrieve this information for eMedicine.
We selected all the systematic reviews signalled by the
American College of Physicians (ACP) Journal Club and
Evidence-Based Medicine Primary Care and Internal Medicine
fromApriltoDecember2009.Thesetwoliteraturesurveillance
journals survey a wide range of international medical journals,
applying strict criteria for the quality and validity of research
articles. Practising clinicians assess studies that meet the basic
validitycriteriaforrelevanceofclinicalimplicationsforpractice
and newsworthiness and a summary is then produced for the
top rated articles. In the same period (April to December 2009)
we selected all the Cochrane systematic reviews labelled as
“conclusion changed” in the Cochrane Library. These are new
citation versions of updated reviews that warrant additional
highlightingintheCochraneLibrary(forexample,withaflag),
indicatingthattheyshouldbereadagain.
9Weassumedthatthis
sampling frame was representative of systematic reviews that
meetexplicitqualitystandardsandaredeemeddirectlyrelevant
to clinical practice.
To evaluate how fast point of care summaries are updated we
used a prospective cohort design over a one year period from
June2009toMay2010.Thefollow-upstartedtwomonthsafter
the collection period to allow the potential citation of the most
recentsystematicreviews.Tworeviewersindependentlychecked
whether each sampled systematic review was cited in at least
one chapter of the five point of care information summaries.
This was done monthly at the same time for each product.
Disagreements were resolved by discussion between the two
reviewers.
Foreachsystematicreviewwedefined“birth”asthepublication
date in one of the two literature surveillance journals or in the
Cochrane Library and “death” (that is, event) as its citation in
the monitored summaries. When the two reviewers agreed on
the inclusion of that evidence in a summary the follow-up for
thatsystematicreviewwasterminatedbytheevent.Wecensored
systematic reviews when they had not been cited by the end of
follow-up or if there was clear evidence that the topic was not
covered by a given summary, similar to losses at follow-up in
survival analyses. Two independent reviewers defined loss to
follow-up. We excluded citations in additional reference lists,
such as further or external readings and alert systems. We kept
an archive of all the reference web pages citing the sampled
systematic reviews.
We did not attempt any formal sample size calculation because
information about the baseline incidence rates of citation was
not available. Instead, we conducted an interim analysis after
sixmonthstodeterminethelengthofthecollectionperiod(that
is,asmalldifferencewouldhaverequiredanextendedcollection
period and hence more systematic reviews). At the interim
analysis we found substantial differences between the top
performer and the other summaries, dramatically boosting the
power of the study. The collection period was then stopped at
nine months (December 2009).
WeassessedthecumulativerateofupdatingusingKaplan-Meier
survivalanalyses.Asthereweresubstantialdifferencesbetween
the top performer and the other summaries, we calculated the
hazardratiosand95%confidenceintervalsforeachcomparison
using a univariate random Cox model. As we conducted an
interim analysis to drive the length of the collection period,
P≤0.025 was considered significant.
We further explored whether systematic reviews were more
likely to be cited by the point of care information summaries
on the basis of their source (literature surveillance journals or
the Cochrane Library). As we observed different patterns of
citationbetweenthetwosecondtotopsummaries,wecompared
the proportions of systematic reviews retrieved from literature
surveillance journals or the Cochrane Library in these two
summaries. Because this exploratory analysis did not aim to
compare the citation rates but only the proportions, we used
logistic regression and have reported the results as odds ratios.
Results
Table 1⇓ describes the updating mechanism for product. For
EBM Guidelines information was obtained after contacting the
editorsbyemail,whileforeMedicinewewereunabletoretrieve
any details on updating. Clinical Evidence declares a target
updating cycle of one year and alerts readers of each specific
chapter about potentially relevant new publications, providing
linkstothefullreference(BMJUpdates).Thesealerts,however,
are not inserted in the chapters or evaluated together with the
existing body of evidence. EBM Guidelines, UpToDate, and
Dynamed refer to “a continuous update,” meaning that new
research findings are incorporated into the summaries every
time they are published. UpToDate is the only product that
clearly reports quantitative data on the topic updated (35% of
all contents during a four month cycle).
From April to December 2009, we retrieved 128 systematic
reviews, 68 from the two literature surveillance journals (53%)
and 60 (47%) from the Cochrane Library. The complete list is
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RESEARCHavailable in the appendix on bmj.com. Overall, 114 systematic
reviews (89%) had been cited by at least one point of care
summary. The median follow-up time was 33 weeks (range
1-60).Table2⇓reportstheproportionsofcitationsbysummaries
overtimeandthehazardratioforeachsummarycomparedwith
the top performer. Dynamed has an updating process that
markedly led the others (fig 1⇓). For instance, the hazard ratios
for citation for EBM Guidelines and Clinical Evidence versus
the top performer were 0.22 (95% confidence interval 0.17 to
0.29) and 0.03 (0.01 to 0.05), respectively. This means that the
updating speed of Dynamed is 78% and 97% greater than those
of EBM Guidelines and Clinical Evidence, respectively. The
median time to citation was 7.7 weeks (range 7-8.2) for
Dynamed and 42 weeks (range 34-maximum not reached) for
EBMGuidelines.Dynamedhasamediancitationrateofaround
two months, EBM Guidelines is around 10 months but quite
close to the limit of our follow-up. The citation rate of the other
three point of care summaries (UpToDate, eMedicine, Clinical
Evidence)weresoslowthattheyexceededthefollow-upperiod
and we could not compute the median.
Dynamed was also the first when we separately analysed the
updating rate for systematic reviews retrieved through the
CochraneLibrary(fig2⇓)andtheliteraturesurveillancejournals
(fig 3⇓). The two second point of care summaries (EBM
Guidelines and UptoDate) had similar updating rates when we
consideredthewholesampleofsystematicreviewsbutdiffered
whenwetooktheoriginofthesystematicreviewsintoaccount.
Cochrane systematic reviews were more likely to be cited by
EBM Guidelines than by UpToDate (odds ratio 0.02, 0.01 to
0.10; P<0.001, logistic regression). EBM Guidelines has a
formal agreement with the Cochrane Collaboration to use
Cochranecontentsandlabelitssummariesas“Cochraneinside.”
Discussion
Evidence held to be relevant to clinical practice is inserted at
differentratesinpointofcareinformationsummaries,andthese
products vary widely in their speed at updating content. Our
citation analysis showed that Dynamed clearly dominates the
otherproducts(ClinicalEvidence,EBMGuidelines,eMedicine,
and UpToDate). Slowness in updating could mean that new
relevantinformationisignoredandcouldthusaffectthevalidity
of point of care information services. Ultimately, whenever the
transferofrelevantinformationisinappropriatelyslow,thiscan
affect the care of patients, potentially denying treatments of
provedbenefit.Thishappensdespitethefactthatmanyofthese
productspromotethemselvestotheclinicalcommunityasbeing
regularly updated with the latest evidence.
When should point of care information
content be updated?
A few studies have looked into strategies for updating clinical
guidelines
2 10-13 and systematic reviews,
14 15 but no definitive
conclusions have been reached on the best approach. A bottom
line common to these studies was that updating is costly and
time consuming. As far as we know, no data are available on
how quickly point of care information content is updated and
so publishers seem to adopt empirical approaches in managing
their updating schedule. Even without an optimal approach, the
updating of point of care information summaries should be
evaluated bearing in mind that these online tools are largely
intended to be used by an audience sensitive to brand new
information.
Reasons for different updating speeds
Differencesinupdatingabilityarepossiblyjustifiedbydifferent
approaches to content development. According to Shekelle et
al, the updating process is based on two phases: identifying
important new evidence and assessing whether it offers new
information that might change recommendations for clinical
practice.
2 In addition, a third phase exists in which the new
evidence should be included in the “old” body of knowledge.
Citing a single trial or a systematic review without appraising
and interpreting this new evidence in the light of existing
knowledge is not enough.
16 In other words, updating is not only
amatterofliteraturesurveillancebutimpliesacriticalevaluation
of what a new item of knowledge adds to other works and what
that means for clinical practice.
6
Referring to these three phases, do these point of care
information summaries differ in their approaches? Some of the
productsweanalysedidentifyimportantnewevidencebyregular
systematicsearchesoractivesurveillanceofpublishedjournals
and other information sources (such as reports from drug
regulatory agencies, public health entities, World Health
Organization, etc). In this phase we detected no major
differencesbetweenproducts.Howthisnewevidenceisdeemed
relevant and then incorporated into the body of the summary
probably largely dictates the different updating speeds. In
Dynamed, the top ranked summary, updating is done centrally
by the editorial team (supported by McMaster University’s
Health Information Research Unit since the end of 2010), and
this might make for more prompt inclusion of evidence. In
Clinical Evidence, one of the lowest ranked, the authors of
chapters are involved and often a new peer review process is
required (R Minhas, editor of Clinical Evidence, personal
communication). This is time consuming so content is likely to
be updated more slowly or, in the worst case, to simply become
out of date. In 2009, the BMJ Group launched the BMJ Best
Practice product by engineering the contents of Clinical
Evidence to fit the purpose of better use at the point of care, but
we did not include it as it was not evaluated in our previous
work.
3 As little information on updating mechanisms was
available for some summaries, our ability to further explore
possibledifferencesinupdatingapproachesislimited.Publishers
should fully elucidate information about their updating
mechanisms.
Limitations
We chose a citational approach to measure updating speed,
though there are shortcomings with this approach. Firstly, the
total number of citations in the point of care information
products should have been taken into account. Secondly,
citationalanalysiscountsonlybibliographicreferenceswithout
going deeply into the content of the citation. This criticism,
widely raised when citational analysis is used to evaluate
scientific productivity and quality,
17 18 also applies to our
assessment. We did not attempt to go beyond the empirical
number of citations found. In fact we did not judge the
appropriateness of the update but simply used the updating
speed as its proxy. Qualitative analysis of the updating process
and how new evidence is incorporated and affects
recommendationsshouldalsobetakenintoaccountinassessing
whether one summary is better than others. Thus we cannot say
that Dynamed is superior to the other products in terms of the
appropriatenessoftheupdatingprocessorthatClinicalEvidence
compensates the limitations of its updating speed by offering
deeper and more insightful updating.
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RESEARCHWe did not directly assess how many systematic reviews in our
sample called for a change in clinical practice as we assumed
that all our sources (ACP Journal Club, Evidence-Based
Medicine,andtheCochraneLibrary)highlightnewsworthyand
relevant evidence through well established selection processes.
Furthermore, these are considered authoritative international
networks that close the gap between medical literature and
clinical practice. We cannot exclude that relevant messages
requiringurgentactionmightbegivenprioritybythepublishers,
thus preserving the quality of the point of care summary. We
chose Cochrane systematic reviews with “conclusion
changed,”—that is, those that should be read again.
9 If a point
of care information summary still cited the old version of the
Cochrane systematic review this was considered not updated,
regardlessofthenatureandimpactofthechangeinconclusions.
We believe this conservative approach, which might have
partially influenced the citing speed of Cochrane systematic
reviews,wasappropriateasknowingthataCochranesystematic
review has been updated could be important for readers. We
are also aware that we relied on sources of pre-appraised
evidence mainly devoted to general practice and internal
medicine,thoughspecialtytopicsareprovidedtoo(seeappendix
onbmj.com).Finally,wedidnotconsidertheupdatingofresults
from studies with other designs (such as randomised clinical
trials) as we think that systematic reviews are preferable to
support decision making at the point of care.
Conclusions
Updating is only one aspect of the overall quality of a point of
careproduct.Otherstudieshaveassessedotherdimensionssuch
as user’s satisfaction, how well different online point of care
services answered questions arising in daily clinical work,
contentdevelopment,andevidencebasedsoundness.
19Findings
frombothuserandcontentcentredanalysesneedtobecombined
if one has to choose one product rather than another. Readers
should be aware that point of care information summaries vary
widely in their updating ability, and, in some cases, it might be
unsatisfactory in relation to what users expect and what
publishers advertise. In the context of an editorial market with
rapidly evolving point of care summaries, our specific intent
was to provide a snapshot assessment of the updating speed of
pointofcareserviceswithrecentlypublishedrelevantsystematic
reviews.Thequantitativefindingsshouldbeconsideredtogether
withaqualitativeanalysisofupdatingmethodsthatcanbedone
only if updating mechanisms are described in greater detail by
publishers.
The process leading from evidence to clinical recommendation
and then to changes in behaviour is affected by many factors
besidesaccesstothelateststudies.
20-22Nevertheless,appropriate
promotion of progressing evidence is essential to provide
patients with better healthcare.
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RESEARCHWhat is already known on this topic
Few studies have compared the quality of point of care summaries
Most looked at user satisfaction as the outcome measure and none evaluated their speed of updating and appropriateness
What this study adds
Point of care information summaries insert latest evidence relevant to practice at different speeds
Tables
Table 1| Description of updating mechanisms reported on website of each point of care information summary
Description of updating policy
“We aim to update Clinical Evidence reviews annually. In addition to this cycle, details of clinically important studies are added to
the relevant reviews throughout the year using the BMJ Updates service. BMJ Updates is produced by collaboration between the
BMJ Group and the internationally acclaimed McMaster University’s Health Information Research Unit to provide clinicians with
access to current best evidence from research. All citations (from over 110 premier clinical journals) are rated by trained researchers
for quality, and then rated for clinical relevance, importance and interest by at least three members of a worldwide panel of practicing
physicians. The final content is indexed by health professionals to allow news of studies to be added to all relevant Clinical Evidence
reviews.”
Clinical Evidence (www.
clinicalevidence.com)
“The final step in DynaMed’s evidence-based methodology is changing conclusions when new evidence alters the best available
evidence. This step is crucial because new evidence is published every day. Having new evidence summaries handled separately
from reviewed content in a manner requiring the clinician to search in two locations to synthesize the entire story would make
finding the best available evidence more difficult. As soon as new evidence is evaluated using the 6 steps governing systematic
processing, it is added to the appropriate DynaMed topic(s) in context. This process allows immediate and comprehensive access
to the best available evidence as it occurs. This process occurs EVERY DAY in DynaMed.”
Dynamed (www.ebscohost.
com/dynamed/)
“Since the first electronic version was published in 1989 the contents of the database have been continuously updated. Over the
years the guidelines have been extensively reviewed and even rewritten several times to include mounting evidence from clinical
studies, comments by external referees, and feedback that has been collected systematically from clinicians who use the database
in their daily practice. There are four updating processes that complement each other: (1) All guidelines are sent to authors and
external reviewers every 2 years for systematic updates; (2) The editorial board meets once a month, and at every meeting, one
speciality or a group of topics are discussed with 1-3 top experts on the field invited to attend; (3) The editorial team produces and
EBM Guidelines* (www.ebmg.
wiley.com)
updates evidence summaries continuously, and whenever the evidence summaries give rise to updates to the guidelines, the
guidelines are updated; (4) The editorial teams of the translated versions of EBM Guidelines systematically check for updating
needs. Updated parts of the text appear in red colour for a minimum of 6 months after the update was made.”
No detailed information on updating policy is reported on website or provided by publisher eMedicine (www.emedicine.
medscape.com)
“UpToDate performs a continuous comprehensive review of the resources listed above (peer-reviewed journals, clinical databases,
etc.) in order to keep the program updated. Topics in UpToDate are revised whenever important new information is published, not
according to any specific time schedule. Updates are integrated carefully, with specific statements as to how the new findings
should be applied clinically. Each topic has a date indicating when the topic was last reviewed and/or modified. On average,
approximately 35% of the topics are updated during each four-month cycle. A subset of those updates can be viewed by searching
on What’s New and then selecting your specialty or area of interest. These updates represent, in our editors’ view, the most
UpToDate(www.uptodate.com)
important new information added during the previous four months. They include Practice Changing UpDates, a compilation of
studies with important or immediate implications for how clinicians practice.”
*From editorial team.
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RESEARCHTable 2| Proportions of citations of 128 systematic reviews by point of care summaries over time (ordered by ranking at nine months) and
hazard ratios between top performer (Dynamed) and other summaries
HR (95% CI) At 9 months (%) At 6 months (%) At 3 months (%) Summary
Reference 87 84 77 Dynamed
0.22 (0.17 to 0.29) 41 31 18 EBM Guidelines
0.14 (0.09 to 0.21) 29 27 23 UpToDate
0.05 (0.03 to 0.09) 12 9 7 eMedicine
0.03 (0.01 to 0.05) 4 1 0 Clinical Evidence
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RESEARCHFigures
Fig 1 Updating curves for relevant evidence (128 systematic reviews) by point of care information summaries (log rank
χ
2=404, P<0.001)
Fig 2 Updating curves of Cochrane reviews (n=60) by point of care information summaries (log rank χ
2=300, P<0.001)
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RESEARCHFig 3 Updating curves of non-Cochrane reviews (n=68) by point of care information summaries (log rank χ
2=188, P<0.001)
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